stonks4u
Sign up free
IRTC logo

IRTC iRhythm Technologies, Inc.

NASDAQ Global Select · Medical - Devices · Healthcare

$126.44
+3.28 (+2.66%)

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—s…

Market Cap: $4.16Bwww.irhythmtech.com

Price (90d)

$127.84
$101.79$110.91$120.04$129.16
Apr 30Aug 7

Signal Score (90d)

160
5087123160
Aug 8Aug 14

Quote

Day Range
$120.54 – $128.00
52-Week Range
$100.85 – $212.00
Volume
$485.1K
Market Cap
$4.16B
50-Day Avg
$116.46
200-Day Avg
$138.96
Prev Close
$123.16
Open
$123.77

Valuation & Ratios

P/E Ratio
-127.65
EPS
$-1.39
P/B Ratio
37.18
P/S Ratio
7.60
Debt/Equity
4.79
Current Ratio
4.63
Dividend Yield
+0.0%
Gross Margin
+70.6%

Returns & Efficiency

Return on Equity
-29.2%
Return on Assets
-4.4%
FCF Yield
+0.6%
EV/EBITDA
-1557.12

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$747.14M$-44.55M$-1.39
2024$591.84M$-113.29M$-3.63
2023$492.68M$-123.41M$-4.04
2022$410.92M$-116.16M$-3.88
2021$322.82M$-101.36M$-3.46

Social Signal Score

61
5d
61
2 mentions
+0.0%
30d
61
4 mentions
+10.8%
60d
61
4 mentions
+17.5%
90d
61
4 mentions
+12.1%
news: 4

Earnings

Thu, Oct 29(in 2 months)

Consensus estimate $0.02 per share

6of 7 quarters beat consensus

Typical surprise +75.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$-0.01 vs $-0.04beat
  • Thu, Apr 30$-0.43 vs $-0.56beat
  • Thu, Feb 19$0.17 vs $0.02beat
  • Thu, Oct 30$-0.06 vs $-0.36beat
  • Thu, Jul 31$-0.32 vs $-0.53beat
  • Thu, May 1$-0.95 vs $-0.89miss

Estimates and results for IRTC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

IRTChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (4)

  • Newszacks.com·1d ago·Neutral

    iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform IRTC's VitalConnect deal expands its cardiac monitoring reach across ambulatory, inpatient and hospital-to-home care while opening new growth opportunities.

    View source ↗
  • Newszacks.com·1d ago·Positive

    Here's Why iRhythm Holdings, Inc. (IRTC) is a Strong Momentum Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    View source ↗
  • Newszacks.com·5d ago·Positive

    iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised IRTC posts 20.1% revenue growth, margin expansion and a higher 2026 outlook while advancing innovation and its Vital Connect acquisition.

    View source ↗
  • Newsprnewswire.com·7d ago·Neutral

    Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm NEW YORK, Aug. 8, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at iRhythm caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended f

    View source ↗